What Types of Hospitals Do Adolescents and Young Adults With Complex Chronic Conditions Use?


Journal

Academic pediatrics
ISSN: 1876-2867
Titre abrégé: Acad Pediatr
Pays: United States
ID NLM: 101499145

Informations de publication

Date de publication:
08 2022
Historique:
received: 03 05 2021
revised: 30 09 2021
accepted: 15 12 2021
pubmed: 23 12 2021
medline: 10 8 2022
entrez: 22 12 2021
Statut: ppublish

Résumé

Hospitalizations for children with complex chronic conditions (CCC) at pediatric hospitals have risen over time. Little is known about what hospital types, pediatric or adult, adolescents, and young adults (AYA) with CCCs use. We assessed the types of hospitals used by AYAs with CCCs. We performed a cross-sectional study of 856,120 hospitalizations for AYAs ages 15-to-30 years with ≥1 CCC in the 2017 National Inpatient Sample. We identified AYA with CCC by ICD-10-CM diagnosis codes using the pediatric CCC classification system version 2. Hospital types included pediatric hospitals (n = 70), adult hospitals with pediatric services (n = 277), and adult hospitals without pediatric services (n = 3975). We analyzed age trends by hospital type and CCC count in 1-year intervals and dichotomously (15-20 vs 21-30 years) with the Cochran-Armitage test. The largest change in pediatric hospitals used by AYA with CCCs occurred between 15 and 20 years with 39.7% versus 7.7% of discharges respectively (P< 0.001). For older AYA (21 to 30 years), 1.0% of discharges occurred at pediatric hospitals, compared with 65.6% at adult hospitals without pediatric services (P < 0.001). Older AYA at pediatric hospitals had more technology dependence (42.5%) versus younger AYA (27.6%, p < 0.001). Most discharges for AYAs ≥21 years with CCCs were from adult hospitals without pediatric services. Higher prevalence of technology dependence and neuromuscular CCCs, as well as multiple CCCs, for AYA 21-to-30 years discharged from pediatric hospitals may be related to specific care needs only found in pediatric settings and challenges transferring into adult hospital care.

Sections du résumé

BACKGROUND AND OBJECTIVE
Hospitalizations for children with complex chronic conditions (CCC) at pediatric hospitals have risen over time. Little is known about what hospital types, pediatric or adult, adolescents, and young adults (AYA) with CCCs use. We assessed the types of hospitals used by AYAs with CCCs.
METHODS
We performed a cross-sectional study of 856,120 hospitalizations for AYAs ages 15-to-30 years with ≥1 CCC in the 2017 National Inpatient Sample. We identified AYA with CCC by ICD-10-CM diagnosis codes using the pediatric CCC classification system version 2. Hospital types included pediatric hospitals (n = 70), adult hospitals with pediatric services (n = 277), and adult hospitals without pediatric services (n = 3975). We analyzed age trends by hospital type and CCC count in 1-year intervals and dichotomously (15-20 vs 21-30 years) with the Cochran-Armitage test.
RESULTS
The largest change in pediatric hospitals used by AYA with CCCs occurred between 15 and 20 years with 39.7% versus 7.7% of discharges respectively (P< 0.001). For older AYA (21 to 30 years), 1.0% of discharges occurred at pediatric hospitals, compared with 65.6% at adult hospitals without pediatric services (P < 0.001). Older AYA at pediatric hospitals had more technology dependence (42.5%) versus younger AYA (27.6%, p < 0.001).
CONCLUSIONS
Most discharges for AYAs ≥21 years with CCCs were from adult hospitals without pediatric services. Higher prevalence of technology dependence and neuromuscular CCCs, as well as multiple CCCs, for AYA 21-to-30 years discharged from pediatric hospitals may be related to specific care needs only found in pediatric settings and challenges transferring into adult hospital care.

Identifiants

pubmed: 34936941
pii: S1876-2859(21)00638-0
doi: 10.1016/j.acap.2021.12.020
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1033-1040

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001425
Pays : United States

Informations de copyright

Copyright © 2021 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.

Auteurs

Ashley M Jenkins (AM)

Division of Hospital Medicine (AM Jenkins, K Auger), Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Internal Medicine (AM Jenkins), University of Cincinnati Medical Center, Cincinnati, OH. Electronic address: ashley_jenkins@urmc.rochester.edu.

Jay G Berry (JG)

Division of General Pediatrics (JG Berry, P Dunbar, B Garrity), Boston Children's Hospital, Harvard Medical School, Boston, Mass.

James M Perrin (JM)

Division of General Academic Pediatrics, Department of Pediatrics (JM Perrin, K Kuhlthau), MassGeneral Hospital for Children, Harvard Medical School, Boston, Mass.

Karen Kuhlthau (K)

Division of General Academic Pediatrics, Department of Pediatrics (JM Perrin, K Kuhlthau), MassGeneral Hospital for Children, Harvard Medical School, Boston, Mass.

Matt Hall (M)

Children's Hospital Association (M Hall), Lenexa, KS.

Peter Dunbar (P)

Division of General Pediatrics (JG Berry, P Dunbar, B Garrity), Boston Children's Hospital, Harvard Medical School, Boston, Mass.

Clarissa Hoover (C)

Family Voices (C Hoover), Albuquerque, NM.

Brigid Garrity (B)

Division of General Pediatrics (JG Berry, P Dunbar, B Garrity), Boston Children's Hospital, Harvard Medical School, Boston, Mass.

Morgan Crossman (M)

Building Bright Futures (M Crossman), Williston, VT.

Katherine Auger (K)

Division of Hospital Medicine (AM Jenkins, K Auger), Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Pediatrics, University of Cincinnati College of Medicine (K Auger), Cincinnati, OH; James M. Anderson Center for Health Systems Excellence (K Auger), Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH